An implementation science framework to understand low coverage in mass dog rabies vaccination.

Publication date: Jul 23, 2025

Dog-mediated human rabies has been greatly reduced in the Americas and eliminated from most high-income countries. However, many countries in Africa, Asia, and parts of Latin America are still struggling with this gruesome disease. Mass dog vaccination, a One Health strategy, is the primary approach for elimination. However, achieving and sustaining appropriate vaccination coverage in endemic areas remains a challenge. Our objective was to apply the Consolidated Framework for Implementation Research (CFIR) in Arequipa, Peru as a guiding tool to understand the barriers faced by different stakeholders. Seven focus groups with 56 participants were conducted to capture community perspectives on rabies and vaccination. A workshop was conducted with two groups of public health personnel (n = 69): mass dog vaccination campaign (MDVC) implementers and authorities, in charge of dog rabies control. With these stakeholders we explored factors contributing to the decrease in MDVC post COVID-19. We used the CFIR approach to understand barriers within five different domains: innovation, outer setting, inner setting, individuals, and implementation. Barriers within the community included insufficient communication, a short vaccination period, and fragmented collaboration among health system coordinators. At the individual level, a decreased perception of rabies risk occurred as both people and their dogs spent more time indoors due to the COVID-19 pandemic (in urban areas). Dog vaccination was deprioritized compared to COVID-19 protection, with individuals focusing on their own vaccinations and avoiding crowded spaces. In periurban areas, longer work hours due to the pandemic’s financial impact left less time for dog vaccinations on weekends. Participants reported confusion caused by private veterinarians, who claimed that government-subsidized vaccines were of poor quality. Among implementers and authorities, the main barriers included insufficient MDVC materials and equipment, unclear responsibilities, and a lack of time to evaluate the campaign after activities. Importantly, financial constraints and fragmented commitment from higher-level institutions posed challenges for proper planning and implementation. We identified barriers and co-designed strategies to improve MDVC participation including strengthening municipal alliances, virtual and physical publicity for events within districts, adequate training for vaccinators, reinforcing vaccinators to remain in fixed spots, and expanding vaccination campaign hours.

Open Access PDF

Concepts Keywords
Africa Areas
Deprioritized Barriers
Peru Campaign
Veterinarians Cfir
Weekends Countries
Covid
Dog
Groups
Mass
Mdvc
Participants
Rabies
Stakeholders
Understand
Vaccination

Semantics

Type Source Name
disease MESH rabies
disease MESH COVID-19
disease MESH confusion
disease IDO quality
disease MESH Neglected Tropical Diseases
pathway REACTOME Reproduction
disease MESH Infectious Disease
pathway REACTOME Infectious disease
drug DRUGBANK Coenzyme M
drug DRUGBANK Telbivudine
disease IDO intervention
disease MESH infection
disease MESH measles
pathway KEGG Measles
disease MESH tuberculosis
pathway KEGG Tuberculosis
disease MESH Chagas disease
pathway KEGG Chagas disease
disease IDO entity
disease MESH zoonotic diseases
disease IDO process
disease IDO facility
drug DRUGBANK Methionine
disease MESH distemper
drug DRUGBANK Methylergometrine
disease MESH lifestyle
drug DRUGBANK Dexketoprofen
drug DRUGBANK Nonoxynol-9
disease MESH death
drug DRUGBANK Spinosad
disease IDO history
drug DRUGBANK Serine
drug DRUGBANK L-Aspartic Acid
disease MESH polio

Original Article

(Visited 5 times, 1 visits today)